Haystack Oncology Competitors and Similar CompaniesClear all
Curie Therapeutics's competitors and similar companies include Xencor and Allucent TX.
 Curie Therapeutics Curie Therapeutics is a company developing radiopharmaceuticals targeted at the treatment of solid tumors. |  Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. |  Allucent TX Allucent (also known as Pharm-Olam) is a contract research organization offering clinical research services (Phase I-IV) to the pharmaceutical, biotechnology, and medical device industries. | |
Founding Date | Founding Date 2021 | Founding Date 1997 | Founding Date 1994 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Woburn, US HQ | Locations Pasadena, US HQ San Diego, US | Locations Chicago, US HQ Scherpenheuvel Zichem, BE Sao Paulo, BR Montréal, CA Zagreb, HR Prague, CZ Paris, FR see more |
Employees | Employees 844% increase | Employees 2604% increase | Employees 4831% decrease |
Funding | |||
Total funding raised | Total funding raised $ 75m | Total funding raised $ 108.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Xencor
HQ
Pasadena, US
Employees
260↑ 4% increase
Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyAllucent TX
HQ
Chicago, US
Allucent (also known as Pharm-Olam) is a contract research organization offering clinical research services (Phase I-IV) to the pharmaceutical, biotechnology, and medical device industries.
View company